Blog & News

Exploring Spravato: A Breakthrough for Treatment-Resistant Depression

Spravato, an FDA-approved esketamine nasal spray, offers new hope for treatment-resistant depression, with Aspire TMS Clinic providing personalized, comprehensive care

November 13, 2025 No Comments

Ready to get started?

Find out if ASPIRE Clinic can help you or a loved one

By using our website, you agree to accept our clinic policies. Our policies are frequently updated and Aspire Clinic reserve the right to revise it periodically.

Call today.

Blog & News

Ready to get started?

By using our website, you agree to accept our clinic policies. Our policies are frequently updated and Aspire Clinic reserve the right to revise it periodically.

Quick links

Contact

Resources

© All rights reserved by ASPIRE Clinic